AlphaGene is a privately held - functional genomics company offering products and services to biotech and pharmaceutical companies engaged in drug discovery and development. AlphaGene uses its large inventory of full-length, novel cDNAs and bioinformatics expertise to bridge the gap between genomics and functional proteomics. The company focuses on differential gene expression to identify potential drug targets, primarily for oncological and serious degenerative neurological diseases.